Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema
Saved in:
Main Authors: | Floor M. Garritsen (Author), Jorien van der Schaft (Author), Marlies de Graaf (Author), Dirk Jan Hijnen (Author), Carla A.F. Bruijnzeel-Koomen (Author), Marcel P.H. van den Broek (Author), Marjolein S. De Bruin-Weller (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs
by: Floor M. Garritsen, et al.
Published: (2017) -
Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction
by: Ana Luiza Vilar Guedes, et al.
Published: (2017) -
Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Potent Topical Corticosteroids
by: Lieneke F.M. Ariëns, et al.
Published: (2018) -
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
by: Esmé Kamphuis, et al.
Published: (2024) -
Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment
by: Lieneke F.M. Ariëns, et al.
Published: (2019)